New Bill in Italy Aims to Regulate Gender Transition Treatment for Minors
Italy’s government has proposed new legislation intended to regulate medical treatments related to gender transition for minors. This draft law was approved by the cabinet late on Monday but still requires parliamentary approval.
The government argues that the law is necessary to safeguard the health of young people and to ensure proper monitoring of medical data. If passed, the bill will place controls on treatments like puberty blockers and hormones that help individuals under 18 who experience gender dysphoria.
Key Details of the Proposed Law
Under the new bill, minors can only receive these medications after following specific protocols that are yet to be determined by the health ministry. Approval from a national ethics committee made up of pediatricians will also be needed before prescriptions can be issued.
In addition, a national registry will be established by the Italian Medicines Agency to oversee the use of these treatments and to collect medical histories of transgender youth receiving care.
Reactions and Concerns
The proposed legislation has sparked protests among transgender rights advocates, who are worried about the potential impacts on access to necessary healthcare.
Prime Minister Giorgia Meloni has been vocal in her opposition to what she refers to as the “LGBTQ+ lobby” and “gender ideology.” Her government has already implemented policies that make it harder for same-sex couples with children to have both parents recognized legally, and it has banned surrogacy for all couples seeking to have children abroad.
What Happens Next?
While the draft law could still be altered or rejected by parliament, it is expected to pass due to Meloni’s coalition holding a strong majority and being aligned with the bill’s goals. This legislative move is a significant step in Italy’s ongoing debate over gender identity and parental rights.
